DRUG fundamentals
An in-depth look to BRIGHT MINDS BIOSCIENCES INC. operating, investing, and financing activities
DRUG free cash flow for Q3 24 is 240.16 k CAD. For 2023, DRUG free cash flow was -7.02 M CAD and operating cash flow was -7.02 M CAD.
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: CAD
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
TTM